Isanh Conferences

latest innovations, new ingredients and trends in weight loss and weight management/

Nuevos ingredientes, últimas innovaciones y tendencias en la pérdida y la gestión del peso,2 y 3 de Octubre 2008

Paris Nutrigenomics 2008 will bring together industries of diagnostic and nutrition, in order to explore the latest scientific advances in Nutrigenomics fields, and propose perspectives in food, cosmetics and pharmaceuticals. Thus this complete overview on a complex topic will provide keys to understand how industry could benefit of the innovations of Nutrigenomics.

After the great success of the Polyphenols 2006 conference, the International Society for Antioxidants in Nutrition and Health (ISANH) organizes the 4th international meeting to gather high level scientists and professionals to give an update of advances in polyphenols benefits and promising trends of their use in improvement of human health. The conference offers an excellent opportunity to exchange ideas and experiences between researchers and industrialists. Today polyphenols benefits in human health have gained a worldwild interest and the knowlegde of the relationship between their consumption and health improvement is constantly growing. The next step is how to bring these compounds to targeted populations and what are the best means to optimize their effects for consumer.

2nd world congress on prevention and therapies against obesity: innovation and perspectives in the obesity field Obesity is an universally spreaded disease, that concerns not only adults but also children and adolescents. In front of the worlwide epidemy announced by the specialists in this field, Paris Anti-Obesity Therapies 2007 proposes to discuss on the latest therapeutical innovations, the new pathways which will allow the development of new pharmaceutical treatments and the use of natural ingredients to fight against obesity .

The aim of this conference is to bring together world specialists in order to discuss the latest advances on Avian Influenza, especially on new therapeutic targets for treatment and prevention in humans, and the strategies to avoid a human pandemic. A special session will be reserved to discuss about the management of a catastrophic scenario, in the case of a pandemic outbreak.